Showing results (21-30 of 80) with videos related to
Sort By:
Pageof 8
World Journal of Surgery|December 25, 2013
Surgical management of intraabdominal metastases from melanoma: role of the neutrophil to lymphocyte ratio as a potential prognostic factorFerdinando C M Cananzi, Angus Dalgleish, Satvinder MudanJournal of Immunological Methods|May 14, 2005
Cryopreserved dendritic cells for intratumoral immunotherapy do not require re-culture prior to human vaccinationJustin John, Angus Dalgleish, Alan Melcher, et al.Personalized Medicine|May 23, 2018
Biomarkers for development of cancer vaccinesMike Whelan, Graham Ball, Chris Beattie, et al.Investigational New Drugs|January 21, 2014
Rituximab for treating CD20+ prostate cancer with generalized lymphadenopathy: a case report and review of the literatureAngus Dalgleish, Peter Featherstone, Viatcheslav Vlassov, et al.BJU International|May 17, 2005
Immunotherapy of murine prostate cancer using whole tumour cells killed ex vivo by cytosine deaminase/5-fluorocytosine suicide-gene therapyHardev S Pandha, Dorthe Cook, Rebecca Greenhalgh, et al.FEMS Microbiology Letters|September 11, 2004
Novel strains of Salmonella typhimurium as potential vectors for gene deliveryAgnieszka Michael, Richard Stratford, Shahid Khan, et al.Cancer Gene Therapy|April 2, 2005
Immunotherapy of murine prostate cancer using whole tumor cells killed ex vivo by herpes simplex viral thymidine kinase/ganciclovir suicide gene therapyHardev Pandha, Jonathan Eaton, Rebecca Greenhalgh, et al.Frontiers in Immunology|January 30, 2023
Releasing the restraints of Vγ9Vδ2 T-cells in cancer immunotherapyLaura A Ridgley, Jonathan Caron, Angus Dalgleish, et al.Frontiers in Bioscience (Landmark Edition)|June 2, 2012
Expression pattern and targeting of HER family members and IGF-IR in pancreatic cancerNikolaos Ioannou, Alan M Seddon, Angus Dalgleish, et al.BMC Cancer|February 2, 2013
Treatment with a combination of the ErbB (HER) family blocker afatinib and the IGF-IR inhibitor, NVP-AEW541 induces synergistic growth inhibition of human pancreatic cancer cellsNikolaos Ioannou, Alan M Seddon, Angus Dalgleish, et al.Pageof 8